KunWha Pharmaceutical Co., Ltd. (KOSE:A002250) has been chosen as the preferred bidder to buy Hanwha Corp.'s (KOSE:A000880) Dream Pharma Corp., according to sources on July 3, 2014. Kunwha Pharmaceuticals will exercise its right to enter into exclusive negotiations for two weeks.